Management of Heart Failure in the Older Adult: Treatment and Opportunities

Insights

Pharmacists play a crucial role in managing heart failure (HF) pharmacotherapy for elderly patients. Their involvement in transitions of care (TOC) can significantly improve patient outcomes and reduce hospital readmissions.

Area of Science:

  • Geriatric Medicine
  • Cardiology
  • Pharmacology

Background:

  • Heart failure (HF) is a significant cause of illness, death, and hospitalization in older adults.
  • Elderly patients with HF have an increased risk of adverse drug effects and require careful medication management.
  • Transitions of care (TOC) pose a high risk for readmission in geriatric HF patients due to medication issues and communication gaps.

Purpose of the Study:

  • To review evidence on pharmacotherapy for geriatric heart failure.
  • To identify opportunities for pharmacist intervention during transitions of care for this population.

Main Methods:

  • A comprehensive literature search of PubMed was conducted for articles published between 1995 and July 2018.
  • Keywords included heart failure, geriatric, elderly, transitions of care, multidisciplinary, and pharmacist.
  • Relevant original research, reviews, and guidelines were selected and evaluated.

Main Results:

  • Elderly HF patients require specific medication precautions and monitoring due to heightened adverse effect risks.
  • Pharmacists, as part of multidisciplinary teams, can identify and resolve medication-related issues during TOC.
  • Effective interventions can mitigate risks associated with medication changes and improve adherence.

Conclusions:

  • Pharmacists can enhance patient care outcomes in geriatric heart failure.
  • Involvement in TOC processes and providing updated pharmacotherapy recommendations are key pharmacist contributions.

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
232
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
798
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.1K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
737
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
280
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
830